<strong>Vaccine
Volume 28, Issue 16, Pages 2799-2916 (1 April 2010)</strong>
http://www.sciencedirect.com/science/journal/0264410X

<strong><em>Short Communication</em></strong>
<strong>Constructing target product profiles (TPPs) to help vaccines overcome post-approval obstacles</strong>
Pages 2806-2809
Bruce Y. Lee, Donald S. Burke

<em>Abstract</em>
As history has demonstrated, post-approval obstacles can impede a vaccine’s use and potentially lead to its withdrawal. Addressing these potential obstacles when changes in a vaccine’s technology can still be easily made may improve a vaccine’s chances of success. Augmented vaccine target product profiles (TPPs) can help vaccine scientists better understand and anticipate these obstacles and galvanize conversations among various vaccine stakeholders (e.g., scientists, marketers, business development managers, policy makers, public health officials, health care workers, third party payors, etc.) earlier in a vaccine’s development.